ELI LILLY & Co — Director's Dealing 2023

Feb 3, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2023-02-01

Reporting Person: White Anne E. (EVP & Pres, Lilly Neuroscience)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-01	Common Stock	M	7264	—	Acquired	57616	Direct
2023-02-01	Common Stock	F	3252	$344.15	Disposed	54364	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-01	Restricted Stock Unit	$	M	7264	Disposed	2023-02-01	Common Stock (7264.0)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.